India Drug Makers Learn Lesson, Correct Production Process For U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
The spate of U.S. FDA blacklisting of India drug making facilities in the past few years appears to have to a massive cleanup as facilities of firms such as Claris Lifesciences, Dr. Reddy's Laboratories and Sun Pharma join the list of the re-approved.